SAHPRA-2022-0038-V038

Type IB variation for application SAHPRA-2022-0038. Type IB variation: New Dosage Strength for Alzabistat — routine update

Variation Number
SAHPRA-2022-0038-V038
Type
Type IB
Application
SAHPRA-2022-0038
Change
CHG-2023-0038
Status
Completed
Fee
€4,313
Submitted
2024-02-12
Approved
—
Description

Type IB variation: New Dosage Strength for Alzabistat — routine update